John E. Timberlake
Chief Executive Officer at Berkshire Biomedical LLC
Profile
John E.
Timberlake is currently the President & Chief Executive Officer at Berkshire Biomedical LLC and Director at AMF Medical SA. Previously, he worked as the President, CEO, CFO & Director at Valeritas Holdings, Inc. and as the President, Chief Executive Officer & Director at Valeritas, Inc. Prior to that, he was the Vice President-Diabetes Marketing at Sanofi-Aventis U.S.
LLC.
He also worked as a Manager at Deloitte & Touche LLP.
Mr. Timberlake holds an undergraduate degree from Northwest Missouri State University, a graduate degree from Purdue University, and an MBA from Ecole Supérieure de Commerce de Rouen and NEOMA Business School.
John E. Timberlake active positions
Companies | Position | Start |
---|---|---|
Berkshire Biomedical LLC
Berkshire Biomedical LLC Packaged SoftwareTechnology Services Berkshire Biomedical LLC is a medical device company that is pioneering the use of biometric technologies to provide precise and accurate personalized medication delivery to only the authenticated intended user. The private company is based in Dallas, TX. The company's lead product under development is the computerized oral prescription administration system (COPA), a hand-held, automated, personalized oral liquid dispensing system designed to deliver controlled and non-controlled liquid oral medications to only the authenticated intended user upon confirmation of dual biometric identification. The company was founded in 2016 by Thomas M. Rouse, Susan Owen. John E. Timberlake has been the CEO of the company since 2021. | Chief Executive Officer | 2021-04-26 |
AMF Medical SA
AMF Medical SA Electronic Equipment/InstrumentsElectronic Technology Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The private company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million. | Director/Board Member | 2021-09-30 |
Former positions of John E. Timberlake
Companies | Position | End |
---|---|---|
VALERITAS INC | Chief Executive Officer | 2020-04-01 |
VALERITAS HOLDINGS, INC. | Chief Executive Officer | 2020-04-01 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Sales & Marketing | 2005-12-31 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 1990-12-31 |
Training of John E. Timberlake
Northwest Missouri State University | Undergraduate Degree |
Purdue University | Graduate Degree |
NEOMA Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 7 |
---|---|
Valeritas Holdings, Inc.
Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Valeritas Holdings, Inc. develops and commercializes insulin delivery devices. The company was founded by Leisa Swanson and Robert R. Gonnelli on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Ecole Supérieure de Commerce de Rouen | Consumer Services |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
Berkshire Biomedical LLC
Berkshire Biomedical LLC Packaged SoftwareTechnology Services Berkshire Biomedical LLC is a medical device company that is pioneering the use of biometric technologies to provide precise and accurate personalized medication delivery to only the authenticated intended user. The private company is based in Dallas, TX. The company's lead product under development is the computerized oral prescription administration system (COPA), a hand-held, automated, personalized oral liquid dispensing system designed to deliver controlled and non-controlled liquid oral medications to only the authenticated intended user upon confirmation of dual biometric identification. The company was founded in 2016 by Thomas M. Rouse, Susan Owen. John E. Timberlake has been the CEO of the company since 2021. | Technology Services |
AMF Medical SA
AMF Medical SA Electronic Equipment/InstrumentsElectronic Technology Part of Tandem Diabetes Care, Inc., AMF Medical SA is a Swiss medtech company that was founded in 2014. The private company is based in St-Sulpice, Switzerland. The company is developing a novel technology called Sigi™, a next-generation interoperable, semi-reusable, and rechargeable patch pump that uses standard pre-filled insulin cartridges. Sigi™ is designed to make life easier for people with diabetes and received breakthrough device designation by the Food and Drug Administration in November 2021. The company is led by co-CEOs Mr. Pim van Wesel and Mr. Antoine Barraud, PhD, who is also a co-founder. AMF Medical was acquired by Tandem Diabetes Care, Inc. on January 19, 2023, for $205.05 million. | Electronic Technology |
Valeritas, Inc.
Valeritas, Inc. Medical SpecialtiesHealth Technology Valeritas, Inc. engages in the development and commercialization of drug delivery solutions for the treatment of diabetes. Its product, V-Go wearable insulin delivery device, which enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin at a continuous preset basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. The company was founded on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- John E. Timberlake